New Chiral Hydrogenation Technology
To promote Cl-MeO-BIPHEP in the international R&D community, Bayer AG has entered into agreement with Strem Chemicals, Inc. to market the ligand in research quantities. Strem, with U.S. headquarters in Newburyport, Mass., is a leading manufacturer and marketer of R&D chemicals. The company is currently selling and shipping orders for the R and S versions of Cl-MeO-BIPHEP (CAS No. 185913-98-8 and 185913-97-7).
Bayer's new synthesis allows the introduction of a wide spectrum of substituents (R-groups) in place of the phenyl group on the phosphorous. "This allows us to fine tune the catalyst more efficiently than was possible before. Previously, the racemic separation took place after the R group was attached. That required working out a separate resolution for each R group," Rudolph Hanko, head of Bayer's Fine Chemicals Business Unit, said. In addition to custom manufacturing, Bayer's Fine Chemicals Business Unit offers its customers process development services. These include finding the most suitable catalyst.
For enantioselective hydrogenation processes, complexes with Cl-MeO-BIPHEP are but one of many possible catalysts. Using fast screening technology, Bayer can quickly and efficiently find the optimal catalyst and reaction conditions. In addition to chiral hydrogenation, Bayer offers its customers access to other advanced chiral technologies. These including Simulated Moving Bed chromatography, crystallization-induced resolution, enzymatic conversion and stereo-specific synthesis.
Most read news
Other news from the department science
These products might interest you
Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances
AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!